Vfend 50 MG Oral Tablet
- RxCUI
- 352218
- RxNorm name
- Vfend 50 MG Oral Tablet
- Display name
- Vfend 50 MG Oral Tablet
- Full name
- Vfend 50 MG Oral Tablet
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:21
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| VFEND | VORICONAZOLE | Roerig | ce3ef5cf-3087-4d92-9d94-9eb8287228db | 2026-02-26 | Warnings, Adverse reactions | 352218 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| ce3ef5cf-3087-4d92-9d94-9eb8287228db | Vfend 50 MG Oral Tablet [PSN] · voriconazole 50 MG Oral Tablet [Vfend] [SBD] · Vfend 50 MG Oral Tablet [SY] | 3 | 58 | These highlights do not include all the information needed to use VFEND safely and effectively. See full prescribing information for VFEND. VFEND ® (voriconazole) tablets, for oral use VFEND ® (voriconazole) for oral suspension VFEND ® (voriconazole) for injection, for intravenous use Initial U.S. Approval: 2002 | 20260226 |